A Study of Telitacicept in Patients With Ocular Myasthenia Gravis (OMG)

Clinical trial NCT07249632 · RECRUITING

Trial details

NCT number: NCT07249632
Sponsor: RemeGen Co., Ltd.
Status: RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Myasthenia Gravis, Ocular

Start date: 2026-01-13
Primary completion: 2026-12-31
Enrollment: 120

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.